Cargando…

The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA

BACKGROUND AND AIM: Methylated SEPT9 is a novel circulating tumor DNA marker for colorectal cancer, while the effects of various colorectal cancer clinicopathological factors on its detection performance have not been fully evaluated. This study aims to investigate the significance of the clinicopat...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Na, Song, Lele, Kang, Qian, Jin, Peng, Cai, Guoxiang, Zhou, Jinfeng, Zhou, Guangpeng, Sheng, Jianqiu, Cai, Sanjun, Wang, Jianming, Han, Xiaoliang, Nie, Yongzhan, Wu, Kaichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144579/
https://www.ncbi.nlm.nih.gov/pubmed/30223720
http://dx.doi.org/10.1177/1533033818791794
_version_ 1783356124527853568
author He, Na
Song, Lele
Kang, Qian
Jin, Peng
Cai, Guoxiang
Zhou, Jinfeng
Zhou, Guangpeng
Sheng, Jianqiu
Cai, Sanjun
Wang, Jianming
Han, Xiaoliang
Nie, Yongzhan
Wu, Kaichun
author_facet He, Na
Song, Lele
Kang, Qian
Jin, Peng
Cai, Guoxiang
Zhou, Jinfeng
Zhou, Guangpeng
Sheng, Jianqiu
Cai, Sanjun
Wang, Jianming
Han, Xiaoliang
Nie, Yongzhan
Wu, Kaichun
author_sort He, Na
collection PubMed
description BACKGROUND AND AIM: Methylated SEPT9 is a novel circulating tumor DNA marker for colorectal cancer, while the effects of various colorectal cancer clinicopathological factors on its detection performance have not been fully evaluated. This study aims to investigate the significance of the clinicopathological factors on methylated SEPT9 performance in a symptomatic endoscopy cohort, with a specific focus on colorectal cancer. METHODS: A total of 1160 participants were recruited in this study, including 300 patients with colorectal cancer, 122 patients with adenoma, 103 patients with hyperplastic polyps, 568 normal participants (no evidence of disease), and 67 patients with other gastrointestinal diseases. Peripheral blood samples of these participants were collected from 3 Chinese hospitals, and the methylated SEPT9 level was measured using the Epi proColon 2.0 assay. RESULTS: Cancer stage, size, and invasion depth were positively correlated with the detection sensitivity, while no difference in sensitivity was identified among cancers at various locations. Infiltrative colorectal cancer exhibited higher sensitivity than ulcerative and protrude colorectal cancer, while no difference in sensitivity was observed among assessed histological types. The colorectal cancer differentiation showed a clear correlation with the cancer stage, and moderate and poorly differentiated colorectal cancer exhibited higher sensitivity than well-differentiated colorectal cancer. Furthermore, colorectal cancer with distal metastasis (M1) showed higher sensitivity than those without any metastasis, while colorectal cancer with lymph node metastasis (N1 and N2) did not show statistical significance compared to those without it. Finally, local vessel or nerve invasion did not affect the sensitivity. CONCLUSION: Factors that reflect the colorectal cancer intrinsic properties, including cancer stage, size, invasion depth, classification, differentiation, and metastasis, exhibited significant effect on the mSEPT9 detection performance.
format Online
Article
Text
id pubmed-6144579
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-61445792018-09-21 The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA He, Na Song, Lele Kang, Qian Jin, Peng Cai, Guoxiang Zhou, Jinfeng Zhou, Guangpeng Sheng, Jianqiu Cai, Sanjun Wang, Jianming Han, Xiaoliang Nie, Yongzhan Wu, Kaichun Technol Cancer Res Treat Original Article BACKGROUND AND AIM: Methylated SEPT9 is a novel circulating tumor DNA marker for colorectal cancer, while the effects of various colorectal cancer clinicopathological factors on its detection performance have not been fully evaluated. This study aims to investigate the significance of the clinicopathological factors on methylated SEPT9 performance in a symptomatic endoscopy cohort, with a specific focus on colorectal cancer. METHODS: A total of 1160 participants were recruited in this study, including 300 patients with colorectal cancer, 122 patients with adenoma, 103 patients with hyperplastic polyps, 568 normal participants (no evidence of disease), and 67 patients with other gastrointestinal diseases. Peripheral blood samples of these participants were collected from 3 Chinese hospitals, and the methylated SEPT9 level was measured using the Epi proColon 2.0 assay. RESULTS: Cancer stage, size, and invasion depth were positively correlated with the detection sensitivity, while no difference in sensitivity was identified among cancers at various locations. Infiltrative colorectal cancer exhibited higher sensitivity than ulcerative and protrude colorectal cancer, while no difference in sensitivity was observed among assessed histological types. The colorectal cancer differentiation showed a clear correlation with the cancer stage, and moderate and poorly differentiated colorectal cancer exhibited higher sensitivity than well-differentiated colorectal cancer. Furthermore, colorectal cancer with distal metastasis (M1) showed higher sensitivity than those without any metastasis, while colorectal cancer with lymph node metastasis (N1 and N2) did not show statistical significance compared to those without it. Finally, local vessel or nerve invasion did not affect the sensitivity. CONCLUSION: Factors that reflect the colorectal cancer intrinsic properties, including cancer stage, size, invasion depth, classification, differentiation, and metastasis, exhibited significant effect on the mSEPT9 detection performance. SAGE Publications 2018-09-17 /pmc/articles/PMC6144579/ /pubmed/30223720 http://dx.doi.org/10.1177/1533033818791794 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
He, Na
Song, Lele
Kang, Qian
Jin, Peng
Cai, Guoxiang
Zhou, Jinfeng
Zhou, Guangpeng
Sheng, Jianqiu
Cai, Sanjun
Wang, Jianming
Han, Xiaoliang
Nie, Yongzhan
Wu, Kaichun
The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA
title The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA
title_full The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA
title_fullStr The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA
title_full_unstemmed The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA
title_short The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA
title_sort pathological features of colorectal cancer determine the detection performance on blood ctdna
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144579/
https://www.ncbi.nlm.nih.gov/pubmed/30223720
http://dx.doi.org/10.1177/1533033818791794
work_keys_str_mv AT hena thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT songlele thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT kangqian thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT jinpeng thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT caiguoxiang thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT zhoujinfeng thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT zhouguangpeng thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT shengjianqiu thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT caisanjun thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT wangjianming thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT hanxiaoliang thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT nieyongzhan thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT wukaichun thepathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT hena pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT songlele pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT kangqian pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT jinpeng pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT caiguoxiang pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT zhoujinfeng pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT zhouguangpeng pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT shengjianqiu pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT caisanjun pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT wangjianming pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT hanxiaoliang pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT nieyongzhan pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna
AT wukaichun pathologicalfeaturesofcolorectalcancerdeterminethedetectionperformanceonbloodctdna